It can regulate a series of inflammation-related signal pathways, such as IL6/JAK-STAT3, IL2-STAT5, and TNFα signaling pathways, in which the IL-6/JAK-STAT3 pathway is abnormally activated in many cancers, and hyperactivity is usually associated with poor clinical prognosis. The gene discussed is IL2; the disease is cancer.